These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7472911)

  • 21. Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile.
    Limaye AP; Turgeon DK; Cookson BT; Fritsche TR
    J Clin Microbiol; 2000 Apr; 38(4):1696-7. PubMed ID: 10747174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is "negative" positive?
    Surawicz CM
    Am J Gastroenterol; 1999 Oct; 94(10):3060-1. PubMed ID: 10520871
    [No Abstract]   [Full Text] [Related]  

  • 23. How to detect Clostridium difficile variant strains in a routine laboratory.
    Rupnik M
    Clin Microbiol Infect; 2001 Aug; 7(8):417-20. PubMed ID: 11591204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.
    Merz CS; Kramer C; Forman M; Gluck L; Mills K; Senft K; Steiman I; Wallace N; Charache P
    J Clin Microbiol; 1994 May; 32(5):1142-7. PubMed ID: 8051237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clostridium difficile].
    Okada J
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():224-6. PubMed ID: 20942043
    [No Abstract]   [Full Text] [Related]  

  • 26. What is the true burden of Clostridium difficile disease?
    Wren MW; Coen PG; Shetty NP
    J Hosp Infect; 2007 Oct; 67(2):196-7. PubMed ID: 17884251
    [No Abstract]   [Full Text] [Related]  

  • 27. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
    Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
    J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease.
    Sharp SE; Ruden LO; Pohl JC; Hatcher PA; Jayne LM; Ivie WM
    J Clin Microbiol; 2010 Jun; 48(6):2082-6. PubMed ID: 20375230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis.
    Farrell RJ; LaMont JT
    Curr Top Microbiol Immunol; 2000; 250():109-25. PubMed ID: 10981360
    [No Abstract]   [Full Text] [Related]  

  • 30. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?
    Gilligan PH
    J Clin Microbiol; 2008 Apr; 46(4):1523-5. PubMed ID: 18256226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat Clostridium difficile Testing.
    Gupta A; Khanna S
    JAMA; 2016 Dec; 316(22):2422-2423. PubMed ID: 27959982
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.
    Sloan LM; Duresko BJ; Gustafson DR; Rosenblatt JE
    J Clin Microbiol; 2008 Jun; 46(6):1996-2001. PubMed ID: 18434563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy.
    Adler SP; Chandrika T; Berman WF
    Am J Dis Child; 1981 Sep; 135(9):820-2. PubMed ID: 7282658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Clostridium difficile cytotoxin and Clostridium perfringens enterotoxin in cases of diarrhoea in the community.
    Forward LJ; Tompkins DS; Brett MM
    J Med Microbiol; 2003 Sep; 52(Pt 9):753-757. PubMed ID: 12909650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
    Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A.
    Warny M; Denie C; Delmée M; Lefebvre C
    Acta Clin Belg; 1995; 50(1):36-9. PubMed ID: 7537003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of toxigenic Clostridium difficile in paediatric patients.
    Falces-Romero I; Troyano-Hernáez P; García-Bujalance S; Baquero-Artigao F; Mellado-Peña MJ; García-Rodríguez J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):357-361. PubMed ID: 28689671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of ImmunoCard Toxins A&B and the new semiautomated Vidas Clostridium difficile Toxin A&B tests for diagnosis of C. difficile infection.
    Alcalá L; Marín M; Madrid M; Domínguez-García E; Catalán P; Peláez MT; Sánchez-Somolinos M; Bouza E
    J Clin Microbiol; 2010 Mar; 48(3):1014-5. PubMed ID: 20071550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.